News LEO Pharma's Adtralza approved by MHRA, EC for adolescent at... The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC) have
News Novartis' new SMA gene therapy cleared in EU Novartis has secured EU approval for Itvisma, a new formulation of its spinal muscular atrophy gene therapy usable in a broader patient population.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
